Richard Staines discusses what has become one of the worst deals in pharma’s history – AbbVie’s purchase of Stemcentrx and its lung cancer drug Rova-T. Rova-T was supposed to be the cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback